Colonisation endpoints in Streptococcus pneumoniae vaccine trials.

Auranen, Kari; Rinta-Kokko, Hanna; Goldblatt, David; Nohynek, Hanna; O'Brien, Katherine L; Satzke, Catherine; Simell, Birgit; Tanskanen, Antti; Käyhty, Helena

Auranen, Kari; Rinta-Kokko, Hanna; Goldblatt, David; Nohynek, Hanna; O'Brien, Katherine L; Satzke, Catherine; Simell, Birgit; Tanskanen, Antti; Käyhty, Helena.

Afiliação

Auranen K; Department of Vaccination and Immune Protection, National Institute for Health and Welfare (THL), P.O. BOX 30, FI-00271, Helsinki, Finland. Electronic address: kari.auranen@thl.fi.
Rinta-Kokko H; Department of Vaccination and Immune Protection, National Institute for Health and Welfare (THL), P.O. BOX 30, FI-00271, Helsinki, Finland.
Goldblatt D; University College London Medical School, Institute of Child Health, London, UK.
Nohynek H; Department of Vaccination and Immune Protection, National Institute for Health and Welfare (THL), P.O. BOX 30, FI-00271, Helsinki, Finland.
O'Brien KL; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Satzke C; Pneumococcal Research and Infectious Diseases and Microbiology, Murdoch Childrens Research Institute, Royal Children's Hospital, Parkville, VIC, Australia; Department of Microbiology and Immunology, The University of Melbourne, Parkville, VIC, Australia.
Simell B; Department of Vaccination and Immune Protection, National Institute for Health and Welfare (THL), P.O. BOX 30, FI-00271, Helsinki, Finland.
Tanskanen A; Department of Vaccination and Immune Protection, National Institute for Health and Welfare (THL), P.O. BOX 30, FI-00271, Helsinki, Finland.
Käyhty H; Department of Vaccination and Immune Protection, National Institute for Health and Welfare (THL), P.O. BOX 30, FI-00271, Helsinki, Finland.

Vaccine ; 32(1): 153-8, 2013 Dec 17.

Article em En | MEDLINE | ID: mdl-24016803

Assuntos

Infecções Pneumocócicas/microbiologia; Infecções Pneumocócicas/prevenção & controle; Vacinas Pneumocócicas/imunologia; Streptococcus pneumoniae/imunologia; Portador Sadio/microbiologia; Estudos Transversais; Humanos; Nasofaringe/imunologia; Nasofaringe/microbiologia; Avaliação de Resultados em Cuidados de Saúde; Infecções Pneumocócicas/epidemiologia; Prevalência

Palavras-chave

NVT; Nasopharyngeal colonisation; OR; PCV; Pneumococcus; Trial endpoint; VE(T); VE(acq); VE(col); VT; Vaccine efficacy; combined vaccine efficacy against acquisition and duration of colonisation; non-vaccine (sero)type(s); odds ratio; pneumococcal conjugate vaccine; vaccine (sero)type(s); vaccine efficacy against acquisition of colonisation; vaccine efficacy against colonisation

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Pneumocócicas / Streptococcus pneumoniae / Vacinas Pneumocócicas Tipo de estudo: Guideline / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Vaccine Ano de publicação: 2013 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google